The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo

Publisher: John Wiley & Sons Inc

E-ISSN: 1476-5381|172|18|4535-4545

ISSN: 0007-1188

Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.18, 2015-09, pp. : 4535-4545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract